Skip to main content
Clinical Trials/PACTR202311470737025
PACTR202311470737025
Not yet recruiting
Phase 3

Child Health and Infection with Low Density (CHILD) Malaria, a randomized controlled trial to assess the long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania

niversity of California San Francisco0 sites600 target enrollmentOctober 25, 2023
ConditionsMalaria

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Malaria
Sponsor
niversity of California San Francisco
Enrollment
600
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of California San Francisco

Eligibility Criteria

Inclusion Criteria

  • 1\. 6 months to 10 years.
  • 2\. Primary residence in the study area during the study period.
  • 3\. Agree to come to study clinic for any illness.
  • 4\. Agree to avoid medications outside of study, even herbal medication.

Exclusion Criteria

  • 1\. Another child from household already randomly selected for recruitment.
  • 2\. Not able or does not provide informed consent.
  • 3\. Need for emergency intervention.
  • 4\. Known history of chronic illness requiring regular specialty care including diabetes mellitus, cancer, or Stage 3 or 4 HIV/AIDS.
  • 5\. Contraindications to artemether\-lumefantrine including history of allergic reaction, weight under 5 kg.
  • 6\. Participation in another active/on\-going intervention trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials